Abstract
Background The purpose of this study was to report the safety and performance of aspiration thrombectomy for patients with acute ischemic stroke (AIS) due to anterior circulation large vessel occlusion (LVO) and late onset to treatment.
Methods This is a retrospective subset analysis of a global prospective multicenter registry (COMPLETE) that enrolled adults with AIS due to LVO and a pre-stroke modified Rankin Scale score (mRS) of 0 or 1 who were treated with aspiration thrombectomy with the Penumbra System. This subset analysis included all patients in the registry who had anterior circulation LVO, an Alberta Stroke Program Early CT Score of at least 6, and late onset to treatment (>6 hours from stroke onset to puncture).
Results Of the 650 patients in the COMPLETE registry, 167 were included here. The rate of successful revascularization at the end of the procedure was 83.2% (139/167), the rate of good functional outcome (mRS 0-2) at 90 days was 55.4% (87/157), and the all-cause mortality rate at 90 days was 14.4% (24/167). No device-related serious adverse events (SAEs) occurred.
Procedure-related SAEs occurred in 9 patients (5.4%) within 24 hours and in 12 patients (7.2%) overall. No significant difference was detected between the outcomes of patients with an onset to puncture time of greater than 6 hours and less than or equal to 12 hours and the outcomes of patients with an onset to puncture time of greater than 12 hours.
Conclusions For patients with AIS due to anterior circulation LVO and with late onset to treatment, aspiration thrombectomy with the Penumbra System appears to be safe and effective. The rates of good functional outcome and all-cause mortality from this study compared favorably with those rates from the medical management arms of the DAWN and DEFUSE-3 studies.
Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03464565.
Competing Interest Statement
Dr Hassan reports consultant/speaker fees from Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai, Insera Therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, and Galaxy Therapeutics; principal investigator for COMPLETE study (Penumbra), LVO SYNCHRONISE (Viz.ai), Millipede Stroke Trial (Perfuze), and RESCUE - ICAD (Medtronic); steering committee/publication committee member for SELECT, DAWN, SELECT 2, EXPEDITE II, EMBOLISE, CLEAR, ENVI, DELPHI, and DISTALS; and DSMB for the COMAND trial. Dr Fifi reports personal fees from Penumbra, Stryker, Microvention, and Cerenovus; ownership interest in Imperative Care; and grants from Viz.ai. Dr Zaidat reports grants and personal fees from Penumbra and four other companies and patents pending or issued for aneurysm and stroke device(s).
Clinical Trial
NCT03464565
Funding Statement
This study was funded by Penumbra, Inc (Alameda, CA). Drs Hassan, Fifi, and Zaidat were the study's principal investigators and were involved in study design. The sponsor was responsible for database setup, site monitoring, data management, and statistical analysis.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1.Ethikkommission der Friedrich-Alexander-Universität Erlangen-Nürnberg of Universitätsklinikum Erlangen gave ethical approval for this work. 2.AdventHealth Orlando IRB of AdventHealth Orlando gave ethical approval for this work. 3.HCA - HealthONE IRB of Radiology Imaging Associates, P.C. gave ethical approval for this work. 4.Ethikkommission zu Lübeck - Universität zu Lübeck of Universitätsklinikum Schleswig-Holstein Campus Lübeck gave ethical approval for this work. 5.WCG IRB of Northwell Health gave ethical approval for this work. 6.Covenant Health IRB of Fort Sanders Regional Medical Center gave ethical approval for this work. 7.Prisma Health-Midlands IRB of Palmetto Health Richland Hospital gave ethical approval for this work. 8.Houston Methodist Research Institute IRB of Houston Methodist Hospital gave ethical approval for this work. 9.Cedars-Sinai, Office of Research Compliance and Quality Improvement of Cedar Sinai Medical Center gave ethical approval for this work. 10.KUMC (University of Kansas Medical Center) Human Research Protection Program IRB of University of Kansas Medical Center Research Institute gave ethical approval for this work. 11.WCG IRB of Mount Sinai Medical Center gave ethical approval for this work. 12.WCG IRB of McAllen Medical Center gave ethical approval for this work. 13.WCG IRB of Yale New Haven Hospital gave ethical approval for this work. 14.UT (University of Tennessee)-College of Medicine IRB of Erlanger Medical Center gave ethical approval for this work. 15.University of Miami Human Subject Research Office (M809) of Jackson Memorial Hospital gave ethical approval for this work. 16.WCG IRB of The Valley Hospital gave ethical approval for this work. 17.Human Research Committee, Partners HealthCare Systems, Inc. of Brigham & Women’s Hospital gave ethical approval for this work. 18.C.P. P Sud-Ouest et Outre-Mer IV, Cabanis Haut-Centre Hospitalier ESQUIROL of Foundation Ophthalmic Adolphe De Rothschild gave ethical approval for this work. 19.WCG IRB of Swedish Medical Center-Cherry Hill gave ethical approval for this work. 20.WCG IRB of Thomas Jefferson University Hospital gave ethical approval for this work. 21.WCG IRB of Los Robles Hospital gave ethical approval for this work. 22.UTHSC (University of Tennessee Health Science Center) IRB of Semmes Murphey Methodist University Hospital gave ethical approval for this work. 23.Dignity Health IRB of Mercy San Juan Medical Center gave ethical approval for this work. 24.SSMSTL (SSM Health Care St Louis) IRB of SSM St. Clare Healthcare gave ethical approval for this work. 25.St Joseph Health IRB of St Jude Medical Center gave ethical approval for this work. 26.Ochsner Clinic Foundation IRB of Ochsner Medical Center gave ethical approval for this work. 27.NYU School of Medicine’s Office of Science and Research Institutional Review Board 1 of NYU Langone Hospital - Brooklyn gave ethical approval for this work. 28.Sutter Health IRB of Eden Medical Center gave ethical approval for this work. 29.MetroWest Medical Center IRB of Valley Baptist Health System-Harlingen gave ethical approval for this work. 30.Mercy Health North LLC Adult IRB Research Oversight and Education of Mercy Health St. Vincent Medical Center LLC gave ethical approval for this work. 31.WCG IRB of Banner Desert Medical Center gave ethical approval for this work. 32.NCH_IRB of Naples Community Hospital gave ethical approval for this work. 33.Ethik-Kommission der Otto-von-Guericke-Universität an der Medizinischen Fakultät und am Universitätsklinikum Magdeburg A.ö.R of Universitätsklinikum Magdeburg A. ö. R. gave ethical approval for this work. 34.C.P. P Sud-Ouest et Outre-Mer IV, Cabanis Haut of CHU de Bordeaux, Hôpital Pellegrin gave ethical approval for this work. 35.Ethikkommission der Charité Universitätsmedizin Berlin of Charité Universitätsmedizin Berlin gave ethical approval for this work. 36.Sächsische Landesärztekammer - Ethikkommission of Klinikum Chemnitz gGmbH gave ethical approval for this work. 37.Komisja Bioetyczna przy Uniwersytecie Medycznym w Lublinie of Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie gave ethical approval for this work. 38.Comité ético de Investigación Clínica (CEIC) del Hospital Universitario Vall d’Hebron of Hospital Universitari Vall d’Hebron gave ethical approval for this work. 39.Independent Ethics Committee at SBHI (State Budgetary Healthcare Institution) of Davidovsky Moscow City Hospital №23 gave ethical approval for this work. 40.Local Ethics Committee of City Clinical Hospital No. 1 named after N. I. Pirogov of City Clinical Hospital No. 1 named after N. I. Pirogov gave ethical approval for this work. 41.Local Ethics Committee of SPb GBUZ City Multidisciplinary Hospital №2 of Multidisciplinary City Hospital №2 gave ethical approval for this work. 42.CEIC del Hospital Virgen de la Arrixaca of Hospital Clínico Universitario Virgen de la Arrixaca gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No statement.
Non-standard Abbreviations and Acronyms
- ACA
- Anterior communicating artery
- AIS
- Acute ischemic stroke
- ASPECTS
- Alberta Stroke Program Early CT Score
- IRB/EC
- Institutional Review Board/Ethics Committee
- LVO
- Large vessel occlusion
- MCA
- Middle cerebral artery
- mRS
- Modified Rankin Scale score
- mTICI
- Modified thrombolysis in cerebral infarction score
- NIHSS
- National Institutes of Health Stroke Scale
- sICH
- Symptomatic intracranial hemorrhage
